Clinical Trials Logo
  1. Home
  2. Labor, Premature
  3. NCT03682822

Routine Early vs Delayed Amniotomy for Preterm Pregnancies: A Randomized Open Label Trial — Cereal  

Labor, Premature Clinical Trial

Official title:
Comparative Effectiveness of Routine Early Versus Delayed Amniotomy for Pregnancies Less Than 37 Weeks Gestational Age: A Randomized Open Label Trial (CEREAL)

Clinical Trial Summary

To compare the duration of preterm induction of labor in women undergoing early vs. late or no artificial rupture of membranes (AROM). Maternal and neonatal outcomes will also be compared between the two groups.

Clinical Trial Description

Women presenting with a preterm singleton pregnancy between 28.0 and 36.6 weeks of gestation with cephalic lie and a medical indication for induction of labor will be approached for this study. The patient/provider must be attempting induction with the goal of vaginal delivery. Women with ruptured membranes, suspected intrauterine infection, prior uterine scar, fetal demise, or a fetal anomaly will be excluded. Women that agree to the study will be randomized to 2 groups: the "early amniotomy" group and the "late amniotomy" group. Women in the early amniotomy group will undergo artificial rupture of membranes (AROM) prior to reaching cervical dilation of 4 cm. Women in the late amniotomy group may not undergo AROM until they reach cervical dilation of greater than 4 cm or they have been on an oxytocin drip for greater than 10 hours with no cervical change. It is possible that a woman in the late amniotomy group will not undergo AROM at all. The primary outcome under consideration is time in labor. Secondary outcomes include rates of chorioamnionitis, postpartum endometritis, mode of delivery, and neonatal outcomes. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03682822
Study type Interventional
Source The University of Texas Health Science Center, Houston
Contact
Status Terminated
Phase N/A
Start date November 1, 2018
Completion date February 24, 2020
View Details
See also
  Status Clinical Trial Phase
Completed NCT03171480 - Use of Nitrous Oxide Donor for Labor Induction in Women With PreEclampsia Phase 4
Completed NCT00397735 - N-acetylcysteine in Intra-amniotic Infection/Inflammation Phase 1/Phase 2
Completed NCT00209326 - A Proof of Concept Study Assessing the Effect of Four Different Single Bolus Intravenous Doses of FE200440 and Placebo on Stopping Preterm Labor Phase 2
Terminated NCT00137501 - Two Dose Regimens of Nifedipine for the Management of Preterm Labor Phase 3
Terminated NCT00641784 - Tocolytics Trial: Intravenous (IV) Magnesium Versus Oral Nifedpine in Fetal Fibronectin (FFN) Postive Population Phase 3
Withdrawn NCT01206998 - Vaginal Progesterone as a Treatment for Women Active Preterm Labor N/A
Completed NCT00599898 - Nifedipine Compared to Atosiban for Treating Preterm Labor Phase 4
Completed NCT00059683 - Ultrasound-indicated Cerclage to Prevent Premature Birth in High-risk Women N/A
Completed NCT00432250 - The Use of Cervical Length to Reduce Hospital Stay in Women Admitted Because of Preterm Labor. Phase 4
Terminated NCT00116623 - Magnesium Sulfate Versus Indomethacin for Preterm Labor Phase 4
Not yet recruiting NCT04105881 - Correlation Between Vitamin D and B Regulatory Cell in Pregnancy